Canopy Growth(US:CGC) ZACKS·2025-08-08 13:16Core Viewpoint - Canopy Growth Corporation reported a quarterly loss of $0.14 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.15, and an improvement from a loss of $0.37 per share a year ago, indicating a positive earnings surprise of +6.67% [1] Financial Performance - The company posted revenues of $52.13 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 8.81%, and showing an increase from $48.39 million in the same quarter last year [2] - Over the last four quarters, Canopy Growth has surpassed consensus EPS estimates only once [2] Stock Performance - Canopy Growth shares have declined approximately 61.7% since the beginning of the year, contrasting with the S&P 500's gain of 7.8% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the next quarter is -$0.14 on revenues of $48.3 million, and for the current fiscal year, it is -$0.46 on revenues of $198.45 million [7] Industry Context - The Medical - Products industry, to which Canopy Growth belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges for stock performance [8]